- Country: Chile
- Summary: Ppty 534 Adq Dematinib
- CLT Ref No: 131997661
- Deadline: 22 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 57600000
- Notice Type: Tender
- Document Ref. No.: 1380-375-LE25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Products or services: Hydroxyurea These Bidding Rules guide, establish and determine the rules and procedures by which Natural and Legal Persons interested in participating in the call for Public Proposal for the ACQUISITION must be governed. OF IMATINIB, for protein kinase inhibitors in patients at the Dr. Hernán Henríquez Aravena Hospital, hereinafter: “The Hospital”. These Bases refer to the conditions and Technical characteristics required for the “ACQUISITION OF IMATINIB”, in hereinafter “The Medication”, for a validity of twenty-four 24 months
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPpty 534 Adq Dematinib - Chile Tender
The DOCTOR HERNAN HENRIQUEZ ARAVENA HOSPITAL, a Government sector organization in Chile, has announced a new tender for Ppty 534 Adq Dematinib. This tender is published on ChileTenders under CLT Ref No: 131997661 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-22.
The estimated tender value is CLP 57600000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
